← Leaderboards
Faraz Bishehsari
Rush University Medical Center
$6,917,442
Attributed
$7,229,191
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,229,191 · 7
By mechanism
R01$4,230,215 · 2
U01$1,312,357 · 1
K23$945,000 · 1
R21$409,619 · 1
R03$312,000 · 1
R13$20,000 · 1
Top collaborators
- Ali Keshavarzian1 shared
- Xiaobo Zhou1 shared
Most similar at Rush University Medical Center
Same institution · by research overlap
- Elliott Jay Mufson$26,194,959
- David A Bennett$145,760,843
- Lena Al-Harthi$22,435,643
- John Gabrieli$17,547,817
- John W. Burns$18,083,293
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsOrganMalignant NeoplasmsTissuesCircadian RhythmsTumorGenesLinkCircadianResponsePhenotypeCircadian PacemakerImmuneSamplingHigh RiskCancer EtiologyColon CarcinomaPatternHourOrganoidsPathologyBiological RhythmDrug EfficacyMolecular
Grant awards (17)
Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer$1,461,750
R01 · FY2025 · CA · contact PI
Impact of Circadian-Microbiome Interaction on the Gut-Pancreas Axis in Aging$640,435
U01 · FY2025 · AG · contact PI
Microbial-based platform for assessing organ damage in alcohol use disorders (AUD)$603,499
R01 · FY2025 · AA · contact PI
Discovery of Chronotherapeutic Candidate Targets in Pancreatic Cancer$312,000
R03 · FY2025 · OD · contact PI
Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer$798,207
R01 · FY2024 · CA · contact PI
Impact of Circadian-Microbiome Interaction on the Gut-Pancreas Axis in Aging$671,922
U01 · FY2024 · AG · contact PI
Personalized Organoid-Chip Model For Drug Testing in Pancreatic Cancer$120,139
R21 · FY2024 · CA · contact PI
Personalized Organoid-Chip Model For Drug Testing in Pancreatic Cancer$60,641
R21 · FY2024 · CA · contact PI
Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer$703,616
R01 · FY2023 · CA · contact PI
Personalized Organoid-Chip Model For Drug Testing in Pancreatic Cancer$228,839
R21 · FY2023 · CA · contact PI
Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer$663,143
R01 · FY2022 · CA · contact PI
Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis$189,000
K23 · FY2022 · AA · contact PI
Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis$189,000
K23 · FY2021 · AA · contact PI
Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis$189,000
K23 · FY2020 · AA · contact PI
Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis$189,000
K23 · FY2019 · AA · contact PI
Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis$189,000
K23 · FY2018 · AA · contact PI
Circadian Rhythm in GI Health and Disease$20,000
R13 · FY2016 · DK · contact PI